Skip to main content
Medicover logo

Medicover — Investor Relations & Filings

Ticker · MCOV ISIN · SE0009778848 LEI · 5493000E9BUOYMOW2K53 ST Human health and social work activities
Open in API
Filings indexed 285 across all filing types
Latest filing 2022-02-28 Declaration of Voting R…
Country SE Sweden
Listing ST MCOV

About Medicover

https://www.medicover.com/

Medicover is an international healthcare and diagnostic services provider. The company operates through two main divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division delivers a broad range of medical care, including primary care, specialist consultations, and hospital treatment. The Diagnostic Services division offers a comprehensive array of laboratory tests, from routine to advanced diagnostics, serving a wide network of clients. Committed to patient-centric care, Medicover focuses on quality, accessibility, and affordability by investing in modern medical technology and innovation. Its core mission is to improve and sustain the health and wellbeing of its customers.

Recent filings

Filing Released Lang Actions
Number of shares and votes in Medicover
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short press release dated February 28, 2022, announcing a change in the total number of shares and votes due to the conversion of class A shares into class B shares. This directly relates to the company's capital structure and share count. This fits the definition of 'Share Issue/Capital Change' (SHA), which covers changes in capital structure, including share counts resulting from conversions. It is not an earnings release (ER), a dividend notice (DIV), or a director's dealing report (DIRS). Since it is a specific announcement about share structure changes, SHA is the most appropriate code over the general 'RNS'.
2022-02-28 English
Earnings Release 2021
Earnings Release Classification · 1% confidence The document is titled "BOKSLUTSKOMMUNIKÉ JANUARI–DECEMBER 2021" (Year-End Report January–December 2021) and contains detailed financial figures for the fourth quarter and the full year (Helår) 2021, including Net Sales, EBIT, Net Income, EBITDA, and EPS. It also includes a CEO's statement (VD-ORD) discussing performance, strategy, and outlook, and detailed segment breakdowns (Healthcare Services and Diagnostic Services). This structure—comprehensive annual financial results combined with management commentary—is characteristic of a full Annual Report, which in the US context is typically filed as a 10-K. However, since this document is clearly a 'Year-End Report' (Bokslutskommuniké) and not explicitly labeled as a 10-K filing, and given the comprehensive nature covering the entire fiscal year, it aligns best with the definition of an Annual Report (10-K) or a comprehensive Interim/Annual Report (IR/AR). Since it covers the full year and is a detailed financial communication, it is classified as the Annual Report (10-K) equivalent, as it contains the full annual performance data, rather than just an Earnings Release (ER) or a short Audit Report (AR). The length (144,569 chars) confirms it is a substantial document, not a short announcement (RPA/RNS). FY 2021
2022-02-11 Swedish
Audit Report / Information 2021
Audit Report / Information Classification · 1% confidence The document is explicitly titled "YEAR-END REPORT JANUARY–DECEMBER 2021" and contains detailed financial metrics for the Fourth Quarter and the Full Year (FY 2021), including Revenue, Operating Profit (EBIT), Net Profit, EBITDA, and EPS, presented in tables and narrative form. This structure is characteristic of a comprehensive annual financial report. Although it is not explicitly labeled as a '10-K' (which is the SEC filing equivalent), based on the provided definitions, a comprehensive 'Year-End Report' detailing full-year performance aligns best with the Annual Report category (10-K). Since the document provides the full results and analysis, it is not merely an Earnings Release (ER) or a Report Publication Announcement (RPA). Given the context of a global database, '10-K' is the most appropriate classification for a full annual financial report. FY 2021
2022-02-11 English
Förvärv av CDT Medicus i Polen är slutfört
M&A Activity Classification · 1% confidence The document is a press release (Pressmeddelande) announcing the completion of an acquisition (FÖRVÄRV AV CDT MEDICUS I POLEN ÄR SLUTFÖRT). It details the purchase price (56 MEUR), financing, expected contribution to profitability, and the acquired entity's profile. This type of announcement, detailing a significant corporate transaction like an acquisition or takeover bid, aligns directly with the definition for M&A Activity (TAR). It is not a formal regulatory report (like 10-K or IR), nor is it a general earnings release (ER).
2022-01-28 Swedish
The acquisition of CDT Medicus Group in Poland is completed
M&A Activity Classification · 1% confidence The document is a short press release announcing the completion of an acquisition (Medicover's acquisition of CDT Medicus Group). It details the financial terms (56 MEUR, revenue figures) and strategic rationale. This type of announcement, detailing a significant corporate transaction like an acquisition or takeover bid, aligns best with the Merger & Acquisition Activity (TAR) definition. It is not a full financial report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific M&A event.
2022-01-28 English
Förvärvet av NIPD Genetics är slutfört
M&A Activity Classification · 1% confidence The document is a press release dated January 18, 2022, announcing the completion of an acquisition (Medicover acquiring NIPD Genetics). This involves a significant corporate transaction, specifically the purchase of shares leading to a change in ownership percentage (from 18.9% to 87.2%). This type of announcement, detailing a merger or takeover activity, directly corresponds to the 'M&A Activity' category. Reviewing the definitions: - 10-K/IR: Not a full annual or interim report. - ER: Not an earnings release. - CAP: While it involves financing (using existing credit facilities), the primary event is the acquisition itself. - TAR (M&A Activity): Defined as 'Announcements and documents related to merger proposals or takeover bids.' The completion of an acquisition fits this description perfectly. Therefore, the classification is TAR.
2022-01-18 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.